This experiment suggests that AS-IV may regulate the lung and gut microbiota of ALI rats through the "gut-lung" axis, reduce inflammatory factor levels, and improve lung and colon injury, which is related to the inhibition of PI3K/AKT/mTOR signaling pathway expression. Here, AKT1 is linked to acute respiratory distress syndrome.